(Total Views: 392)
Posted On: 01/10/2023 11:30:50 AM
Post# of 36

$PIRS News Article - Pieris Pharmaceuticals Announces $5 Million Milestone from Seagen for Initiation of Phase 1 Trial of CD228 x 4-1BB Bispecific Molecule (Mabcalin SGN-BB228 (PRS-346) https://marketwirenews.com/news-releases/pier...83196.html


My Twitter: WhyteStocks